Heparanase is considered a therapeutic target in anti-cancer therapy [20] since it contributes to several processes, which are crucial for cancer progression, such as proliferation, inflammation, extracellular matrix shaping, angiogenesis, resistance to therapy, and dissemination by metastasis [21]. The gene discussed is HPSE; the disease is cancer.